Sucampo Pharmaceuticals, Inc. (SCMP) Announces Clinical Data On Lubiprostone To Be Presented At Two Upcoming Scientific Conferences
5/1/2014 9:19:29 AM
BETHESDA, Md., May 1, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be presented at the American Pain Society ("APS") Conference in Tampa, Florida and Digestive Disease Week ("DDW") 2014 in Chicago, Illinois. The information regarding both presentations can be found below.
Help employers find you! Check out all the jobs and post your resume.
comments powered by